Contego Medical
Private Company
Total funding raised: $60M
Overview
Contego Medical is a private, commercial-stage medical device company founded in 2016 and headquartered in Raleigh, North Carolina, USA. The company specializes in developing advanced, integrated devices for embolic protection and thrombectomy during vascular interventions, aiming to streamline complex procedures. Its marketed product portfolio includes the Neuroguard IEP and Vanguard IEP systems for integrated embolic protection and the Excipio thrombectomy system. Contego is positioned in the large and growing market for minimally invasive treatments for carotid and peripheral artery disease.
Technology Platform
Integrated Embolic Protection (IEP) platform combining therapeutic devices (e.g., stent delivery systems) with embolic protection filters into single, multi-functional systems to simplify procedures and improve safety.
Funding History
3Opportunities
Risk Factors
Competitive Landscape
Operates in the highly competitive vascular intervention space, competing directly with major players like Boston Scientific, Medtronic, Abbott, and Philips. These competitors offer standalone embolic protection devices, stents, and thrombectomy systems. Contego's differentiation is the integration of these functions into single platforms.